LeonaBio, Inc. Investing Cash Flow
LeonaBio, Inc. (LONA) reported Investing Cash Flow of $794.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- LeonaBio, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $16.33M, a 3603.85% increase year-over-year.
- LeonaBio, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$15.54M.
- LeonaBio, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$14.64M.
- LeonaBio, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $5.65M, a 68.66% decline year-over-year.
- LeonaBio, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$15.89M, a 128.99% decline from fiscal 2024.
- LeonaBio, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $54.83M, a 42.34% decline from fiscal 2023.
- LeonaBio, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $95.09M, a 64.90% increase from fiscal 2022.
- LeonaBio, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $57.66M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $16.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $794.00K 10-Q · filed 2026-08-14 | -$13.84M derived: sum of 3 quarters · filed 2026-08-14 | -$8.19M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$15.54M 10-Q · filed 2026-05-07 | -$30.18M derived: sum of 2 quarters · filed 2026-05-07 | -$24.52M derived: sum of 3 quarters · filed 2026-05-07 | -$24.08M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$14.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$8.98M derived: sum of 2 quarters · filed 2026-03-31 | -$8.54M derived: sum of 3 quarters · filed 2026-08-14 | -$15.89M 10-K · filed 2026-03-31 |
| 2025-09-30 | $5.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $6.09M derived: sum of 2 quarters · filed 2026-08-14 | -$1.26M 10-Q · filed 2025-11-06 | -$4.07M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $441.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$6.91M 10-Q · filed 2026-08-14 | -$9.72M derived: sum of 3 quarters · filed 2026-08-14 | $8.32M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$7.35M 10-Q · filed 2026-05-07 | -$10.16M derived: sum of 2 quarters · filed 2026-05-07 | $7.88M derived: sum of 3 quarters · filed 2026-05-07 | $34.44M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $15.23M derived: sum of 2 quarters · filed 2026-03-31 | $41.79M derived: sum of 3 quarters · filed 2026-03-31 | $54.83M 10-K · filed 2026-03-31 |
| 2024-09-30 | $18.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $44.60M derived: sum of 2 quarters · filed 2025-11-06 | $57.64M 10-Q · filed 2025-11-06 | $64.03M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $26.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $39.60M 10-Q · filed 2025-08-07 | $45.99M derived: sum of 3 quarters · filed 2025-08-07 | $66.68M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $13.04M 10-Q · filed 2025-05-09 | $19.43M derived: sum of 2 quarters · filed 2025-05-09 | $40.12M derived: sum of 3 quarters · filed 2025-05-09 | $72.61M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $6.39M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $27.08M derived: sum of 2 quarters · filed 2025-02-27 | $59.57M derived: sum of 3 quarters · filed 2025-02-27 | $95.09M 10-K · filed 2025-02-27 |
| 2023-09-30 | $20.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $53.18M derived: sum of 2 quarters · filed 2024-11-07 | $88.70M 10-Q · filed 2024-11-07 | $113.34M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $32.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $68.01M 10-Q · filed 2024-08-01 | $92.66M derived: sum of 3 quarters · filed 2024-08-01 | $106.29M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $35.52M 10-Q · filed 2024-05-15 | $60.17M derived: sum of 2 quarters · filed 2024-05-15 | $73.80M derived: sum of 3 quarters · filed 2024-05-15 | $69.34M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $24.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $38.28M derived: sum of 2 quarters · filed 2024-02-22 | $33.82M derived: sum of 3 quarters · filed 2024-02-22 | $57.66M 10-K · filed 2024-02-22 |
| 2022-09-30 | $13.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $9.17M derived: sum of 2 quarters · filed 2023-11-09 | $33.02M 10-Q · filed 2023-11-09 | $54.39M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$4.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $19.39M 10-Q · filed 2023-08-10 | $40.76M derived: sum of 3 quarters · filed 2023-08-10 | $26.56M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $23.85M 10-Q · filed 2023-05-11 | $45.22M derived: sum of 2 quarters · filed 2023-05-11 | $31.02M derived: sum of 3 quarters · filed 2023-05-11 | $42.48M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $21.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $7.17M derived: sum of 2 quarters · filed 2023-03-23 | $18.63M derived: sum of 3 quarters · filed 2023-03-23 | -$4.08M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$14.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$2.74M derived: sum of 2 quarters · filed 2022-11-10 | -$25.45M 10-Q · filed 2022-11-10 | -$141.21M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $11.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$11.25M 10-Q · filed 2022-08-15 | -$127.01M derived: sum of 3 quarters · filed 2022-08-15 | -$221.32M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$22.71M 10-Q · filed 2022-05-12 | -$138.47M derived: sum of 2 quarters · filed 2022-05-12 | -$232.78M derived: sum of 3 quarters · filed 2022-05-12 | -$232.78M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$115.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$210.07M derived: sum of 2 quarters · filed 2022-03-28 | -$210.07M derived: sum of 3 quarters · filed 2022-03-28 | -$210.07M 10-K · filed 2022-03-28 |
| 2020-09-30 | -$94.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$94.31M derived: sum of 2 quarters · filed 2021-11-10 | -$94.31M 10-Q · filed 2021-11-10 | -$93.56M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $3.00K 10-Q · filed 2021-08-16 | $754.00K derived: sum of 3 quarters · filed 2021-08-16 | |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-13 | $752.00K derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $751.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $1.51M 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $755.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |